StockNews.com assumed coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research note published on Saturday. The firm issued a sell rating on the biotechnology company’s stock. OncoSec Medical Stock Performance Shares of ONCS opened at $0.45 on Friday. OncoSec Medical has a 52-week low of $0.40 and a 52-week high of […]